Benjamin Spink
Impact in
-
- Protein purification and stability
- RNA Interference and Gene Delivery
- Muscle Physiology and Disorders
- Glycosylation and Glycoproteins Research
- RNA and protein synthesis mechanisms
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Metabolism, Diabetes, and Cancer 1
- Protein purification and stability 1
- Surgery 3
- Pancreatic function and diabetes 2
- Co-authors
- James A. Spudich (3 shared papers)Willem P.C. Stemmer (4 shared papers)Volker Schellenberger (4 shared papers)Sebastian Doniach (2 shared papers)Sivaraj Sivaramakrishnan (2 shared papers)Jeffrey L. Cleland (3 shared papers)Chia‐Wei Wang (3 shared papers)Wayne To (2 shared papers)
- Journals
- PLoS ONE (2 papers)Journal of Pharmaceutical Sciences (1 paper)Nature Structural & Molecular Biology (1 paper)Molecular Cell (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesNetherlandsSouth Korea
In The Last Decade
Benjamin Spink
8 papers receiving 811 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 526
- Radiology, Nuclear Medicine and Imaging 173
- Cell Biology 122
- Toxicology 25
- Cardiology and Cardiovascular Medicine 158
Countries citing papers authored by Benjamin Spink
This map shows the geographic impact of Benjamin Spink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Spink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Spink more than expected).
Fields of papers citing papers by Benjamin Spink
This network shows the impact of papers produced by Benjamin Spink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Spink. The network helps show where Benjamin Spink may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Spink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 340 | |
| 2 | 2008 | 97 | |
| 3 | 2008 | 89 | |
| 4 | Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. | 1997 | 86 |
| 5 | 2005 | 80 | |
| 6 | 2012 | 57 | |
| 7 | 2012 | 53 | |
| 8 | 2010 | 40 | |
| 9 | 2022 | 0 |
About Benjamin Spink
Benjamin Spink is a scholar working on Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Cell Biology, having authored 9 papers that have together received 842 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (2 papers), Cardiomyopathy and Myosin Studies (2 papers), Cellular Mechanics and Interactions (2 papers), Cholinesterase and Neurodegenerative Diseases (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Diabetes Management and Research (1 paper), Inflammatory Bowel Disease (1 paper) and Protein purification and stability (1 paper). The work is most often cited by research in Molecular Biology (526 citations), Radiology, Nuclear Medicine and Imaging (173 citations), Cell Biology (122 citations), Toxicology (25 citations) and Cardiology and Cardiovascular Medicine (158 citations). Benjamin Spink has collaborated with scholars based in United States, Netherlands and South Korea. Frequent co-authors include James A. Spudich, Willem P.C. Stemmer, Volker Schellenberger, Sebastian Doniach, Sivaraj Sivaramakrishnan, Jeffrey L. Cleland, Chia‐Wei Wang, Wayne To, Yong Yin and Michael D. Scholle. Their work appears in journals such as PLoS ONE, Journal of Pharmaceutical Sciences, Nature Structural & Molecular Biology, Molecular Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.